SHELTON, Conn.--(BUSINESS WIRE)--Pitney Bowes today announced the launch of a new Temu integration within ShipAccel®, its cloud-based shipping and order management solution. The integration is ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
March 2 (Reuters) - U.S. private equity firm Thoma Bravo is in advanced talks to buy third-party logistics provider WWEX Group to create a shipping technology business worth as much as $12 billion, ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
The Gmail mobile apps lack a handful of features found on the website, but Google is now adding the ability to create new labels on Android. Once available, open the navigation drawer for “Create ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...
Thoma Bravo is in talks to merge its shipping software firm Auctane Inc., formerly known as Stamps.com, with third-party logistics provider WWEX Group to form a business that could be worth as much as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results